| 000 | 01368 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513084008.0 | ||
| 264 | 0 | _c19960222 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1016/S0009-9236(96)90024-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaiko, R F | |
| 245 | 0 | 0 |
_aPharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJan 1996 |
||
| 300 |
_a52-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMorphinans _xadministration & dosage |
| 650 | 0 | 4 |
_aOxycodone _xadministration & dosage |
| 650 | 0 | 4 |
_aOxymorphone _xadministration & dosage |
| 650 | 0 | 4 | _aReference Values |
| 700 | 1 | _aBenziger, D P | |
| 700 | 1 | _aFitzmartin, R D | |
| 700 | 1 | _aBurke, B E | |
| 700 | 1 | _aReder, R F | |
| 700 | 1 | _aGoldenheim, P D | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 59 _gno. 1 _gp. 52-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0009-9236(96)90024-7 _zAvailable from publisher's website |
| 999 |
_c8548108 _d8548108 |
||